These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5942193)

  • 41. Usefulness of spironolactone in a specialized heart failure clinic.
    Sligl W; McAlister FA; Ezekowitz J; Armstrong PW
    Am J Cardiol; 2004 Aug; 94(4):443-7. PubMed ID: 15325926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection].
    Daum S; Goerg R; Mack D; Wang D
    Prax Klin Pneumol; 1984 Sep; 38(9):406-11. PubMed ID: 6504840
    [No Abstract]   [Full Text] [Related]  

  • 44. Spironolactone and propranolol in the management of hypertension.
    Akbar fA; Pearce MY
    Br J Clin Pract; 1984 Mar; 38(3):110-4. PubMed ID: 6370284
    [No Abstract]   [Full Text] [Related]  

  • 45. Spironolactone and hydroflumethiazide in the treatment of hypertension.
    Akbar FA; Boston PF; Chapman J; Pearce MY
    Br J Clin Pract; 1981 Sep; 35(9):317-21. PubMed ID: 7034762
    [No Abstract]   [Full Text] [Related]  

  • 46. [Multi-centric study for the evaluation of the antihypertensive efficacy of hydrochlorothiazide and spironolactone association: comparison between 2 dosages schemes].
    Fariello R; Porcellati C; Innocenti PF; Corea L; Roncati G
    Clin Ter; 1983 Jun; 105(6):477-85. PubMed ID: 6617110
    [No Abstract]   [Full Text] [Related]  

  • 47. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
    Aoki K; Sato K
    Arzneimittelforschung; 1982; 32(9):1141-5. PubMed ID: 6756418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites.
    Nevens F; Lijnen P; VanBilloen H; Fevery J
    Hepatology; 1996 May; 23(5):1047-52. PubMed ID: 8621132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hyperkalemia with fatal paralysis in a diabetic patient treated with aldactone].
    Herman E; Radó J
    Orv Hetil; 1967 Jan; 108(2):74-6. PubMed ID: 6038068
    [No Abstract]   [Full Text] [Related]  

  • 50. [EFFECT OF THE MICRONIZED SPIRONOLACTONE-BENZTHIAZIDE ASSOCIATION ON CONGESTIVE CARDIAC INSUFFICIENCY. TEST OF CONTINUOUS TREATMENT].
    TOURNIAIRE A; BLUM J; GUYOT R
    Lyon Med; 1964 Nov; 212():1159-80. PubMed ID: 14233310
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical experience with Dytac.
    Weber JC
    Minerva Med; 1963 Oct; 54(81 Suppl):2996-7. PubMed ID: 5877330
    [No Abstract]   [Full Text] [Related]  

  • 52. Idiopathic oedema: a lesson in differential diagnosis.
    Ramanathan M
    Med J Malaysia; 1994 Sep; 49(3):285-8. PubMed ID: 7845281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Spirolactones and the hypertensive edemo-nephrosic syndrome].
    D'Avossa T
    Ann Ostet Ginecol; 1965 Apr; 87(4):304-9. PubMed ID: 5834214
    [No Abstract]   [Full Text] [Related]  

  • 54. [Daily profile of pulse rate and blood pressure. Use of betablocker-diuretic combination (author's transl)].
    Kirchhoff HW
    MMW Munch Med Wochenschr; 1981 Jan; 123(4):124-8. PubMed ID: 6783878
    [No Abstract]   [Full Text] [Related]  

  • 55. Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Ishii C
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S19-22. PubMed ID: 12688391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of benign essential hypertension with an association of spironolactone and thiabutazide: an open multicenter study in general practice (author's transl)].
    Rhomberg F; Leya A
    Schweiz Rundsch Med Prax; 1981 Dec; 70(50):2269-78. PubMed ID: 7031639
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [General conclusions on the use of Oramyl-Salvoxyl-Wander in the treatment and prevention of edema].
    Castaing J; Videgrain M
    Therapeutique; 1973 Mar; 49(3):191-3. PubMed ID: 4731098
    [No Abstract]   [Full Text] [Related]  

  • 59. [Aldactone].
    Menegol-Couque B; Brard M
    Soins Cardiol; 1985 Feb; (24):I-II. PubMed ID: 3846387
    [No Abstract]   [Full Text] [Related]  

  • 60. Idiopathic edema.
    Berczeller PH
    Hosp Pract (Off Ed); 1994 Apr; 29(4):115, 118. PubMed ID: 8144715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.